Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA

Clinical trial NCT03712345 · TERMINATED

Trial details

NCT number: NCT03712345
Sponsor: InflaRx GmbH
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Granulomatosis With Polyangiitis (GPA)Microscopic Polyangiitis (MPA)

Start date: 2018-10-15
Primary completion: 2020-09-10
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.